February 2004
Reactions Weekly;2/21/2004, Issue 989, p8
Discusses research being done on a woman with acute myelomonocytic leukaemia who developed recall dermatitis at the site of a scald wound during her treatment with cytarabine, etoposide and mitoxantrone. Reference to a study by C. Y. Chu et al, published in the August 2003 issue of "Acta DermatoVenereologica"; Doses of the drugs received by the patient; Adverse events experienced by the patient after the infusion of the drugs; Possible reasons behind scalded wound recall phenomenon.


Related Articles

  • Cytarabine/mitoxantrone.  // Reactions Weekly;9/20/2008, Issue 1220, p10 

    The article describes the case of a 17-year-old girl who developed Rhodococcus equi bacteraemia and Gordonia polyisoprenivorans while receiving cytarabine and mitoxantrone for undifferentiated myeloblastic leukaemia. The patient developed fever, rhinorrhoea and a productive cough a month after...

  • Hematology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS33 

    Presents an abstract of the research manuscript `Response-adapted treatment of de novo acute myeloblastic leukemia (AML): Update of a phase II multi-center study of sequential induction regimens idarubicin/cytarabine and mitoxantrone/etoposide,' by R. van der Jagt, S. Robinson et al from the...

  • Daunorubicin/mitoxantrone.  // Reactions Weekly;6/30/2007, Issue 1158, p12 

    The article describes the case of a boy who developed cardiotoxicity during treatment with daunorubicin and mitoxantrone for acute myeloid leukemia (AML). It references a study by J. S. Rao Mangat et al., published in the June 2007 issue of the "Journal of Heart and Lung Transplantation." The...

  • Mitoxantrone.  // Reactions Weekly;10/8/2011, Issue 1372, p25 

    The article describes the cases of 8 men and 22 women with multiple sclerosis (MS) who developed acute promyelocytic leukaemia (APL) during treatment with mitoxantrone.

  • Mitoxantrone.  // Reactions Weekly;5/28/2011, Issue 1353, p19 

    The article describes the case of a 34-year-old patient diagnosed with multiple sclerosis who presented with acute promyelocytic leukemia (APL) while receiving treatment with mitoxantrone and eventually died, published in the December 2010 issue of the journal "Nervenarzi."

  • mitoxantrone.  // Davis's Drug Guide for Nurses, 10th edition;2007, p807 

    The article presents a nursing guide for mitoxantrone, a drug used for treating acute nonlymphocytic leukemia, advances hormone-refractory prostate cancer, and relapsing-remitting multiple sclerosis. The mechanism of action of the antineoplastic agent is discussed. Information on its...

  • Mitoxantrone.  // Reactions Weekly;2/26/2011, Issue 1340, p29 

    The article describes the cases of a 47-year-old woman and a 53-year-old man who developed acute myeloblastic leukaemia following treatment with mitoxantrone for multiple sclerosis.

  • CML Blast Crisis: Imatinib Plus Chemotherapy Effective for Some. Ershler, William B. // Clinical Oncology Alert;May2007, Vol. 23 Issue 5, p37 

    TREATMENT OF BLAST CRISIS REMAINS A MAJOR challenge. In the current report, Fruehauf and colleagues describe their experience in a phase I/II trial in which patients were treated with imatinib, mitoxantrone, and etoposide using four different treatment schedules. In each schedule, the...

  • Fluconazole/mitoxantrone.  // Reactions Weekly;4/7/2007, Issue 1146/1147, p17 

    The article presents the case of a 61-year-old woman who developed torsade de pointes during treatment with mitoxantrone for acute myeloid leukaemia and fluconazole for candidaemia. She was treated with fluconazole 200 milligrams per day and mitoxantrone before admission. Through an...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics